Table 1.

Comparison of included and excluded patients.

	Included in primary analysis	Excluded in primary analysis
Number of unique patients	54	18
Total number of treatment attempts	60	26
Number of patients receiving	6 (11.1%)	8 (44.4%)
two treatments
Age, mean (SD)	48.6 (11.7)	47.4 (8.1)
Sex, n (%)
Male	2 (3.7%)	0 (0.0%)
Female	52 (96.3%)	18 (100%)
Current opioid use	2 (3.7%)	0 (0.0%)
Years with migraine.	29.4 (13.5)	23.4 (12.4)
mean (SD)
Migraine frequency, n (%)
Chronic migraine	22 (40.7%)	7 (38.9%)
High-frequency episodic	13 (24.1%)	4 (22.2%)
migraine
Low-frequency episodic migraine	19 (35.2%)	7 (38.9%)
Treatments, n (% of treatments)
Dexamethasone	13 (21.7%)	8 (30.8%)
Ketorolac	9 (15.0%)	4 (15.4%)
Naratriptan	9 (15.0%)	4 (15.4%)
Nerve block	29 (48.3%)	10 (38.5%)